LDLR and Hypercholesterolemia: On the contrary, blockade of vasa vasorum angiogenesis not only attenuates early neointima formation in experimental hypercholesterolemia (26), but also reduces plaque growth in atherogenic female LDLR(-/-)ApoB-48-deficient mice (27).